{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:04:50Z","timestamp":1776999890956,"version":"3.51.4"},"reference-count":45,"publisher":"Impact Journals, LLC","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,13]]},"DOI":"10.18632\/oncotarget.13306","type":"journal-article","created":{"date-parts":[[2016,11,12]],"date-time":"2016-11-12T02:32:27Z","timestamp":1478917947000},"page":"83817-83827","source":"Crossref","is-referenced-by-count":7,"title":["Placental immune editing switch (PIES): learning about immunomodulatory pathways from a unique case report"],"prefix":"10.18632","volume":"7","author":[{"given":"Miguel H.","family":"Bronchud","sequence":"first","affiliation":[{"name":"Institut Bellmunt Oncologia, Hospital Universitario Dexeus. Grupo Quir\u00f3n Salud, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Tresserra","sequence":"additional","affiliation":[{"name":"Servei Anatomia Patol\u00f2gica, Hospital Universitario Dexeus. Grupo Quir\u00f3n Salud, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Xu","sequence":"additional","affiliation":[{"name":"Nanostring Technologies, Immune Oncology, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Warren","sequence":"additional","affiliation":[{"name":"Nanostring Technologies, Immune Oncology, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maite","family":"Cusido","sequence":"additional","affiliation":[{"name":"Ginecologia Oncol\u00f2gica, Hospital Universitario Dexeus. Grupo Quir\u00f3n Salud, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernat","family":"Zantop","sequence":"additional","affiliation":[{"name":"Servei Obstetricia i Neonatologia, Hospital Universitario Dexeus. Grupo Quir\u00f3n Salud, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Claudia","family":"Zenclussen","sequence":"additional","affiliation":[{"name":"Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cesano","sequence":"additional","affiliation":[{"name":"Nanostring Technologies, Immune Oncology, Seattle, WA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,11]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev.immunol.21.120601.141040","article-title":"Tolerogenic dendritic cells","volume":"21","author":"Nussenzweig","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2003.tb06029.x","article-title":"Dendritic cell functionduring the steady state: a role in peripheral tolerance","volume":"987","author":"Nussenzweig","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0065-2776(06)90008-X","article-title":"Checkpoint blockade in cancer immunotherapy","volume":"90","author":"Allison","year":"2006","journal-title":"Adv Immunol"},{"issue":"4","key":"4","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1200\/JCO.2005.09.923","article-title":"CTLA-4 blockade: unveiling immune regulation","volume":"23","author":"Dranoff","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"2","key":"5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/138161206775193046","article-title":"Mechanisms of CTLA-4-Ig in tolerance induction","volume":"12","author":"Fallarino","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"4","key":"6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00262-004-0593-x","article-title":"Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy","volume":"54","author":"Mackensen","year":"2005","journal-title":"Cancer Immunol Immunother CII"},{"issue":"4","key":"7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1084\/jem.20051776","article-title":"Tissue expression of PD-L1 mediates peripheral T cell tolerance","volume":"203","author":"Sharpe","year":"2006","journal-title":"J Exp Med"},{"key":"8","first-page":"293","volume-title":"Principles of Molecular Oncology","author":"Workman","year":"2008","edition":"3"},{"key":"9","first-page":"320","article-title":"Some immunological and endocrinological problems raised by the evolution of viviparity in vertebrates","volume":"7","author":"Medawar","year":"1953","journal-title":"Soc Exp Biol"},{"issue":"6","key":"10","first-page":"3345","article-title":"Maternal acceptance of the fetus: true human tolerance","volume":"178","author":"Sayegh","year":"2007","journal-title":"J Immunol Baltim Md 1950"},{"issue":"1","key":"11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/molehr\/5.1.84","article-title":"The CTLA-4 gene is expressed in placental fibroblasts","volume":"5","author":"Ober","year":"1999","journal-title":"Mol Hum Reprod"},{"issue":"2","key":"12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijgo.2006.01.027","article-title":"Expression of CD28 and cytotoxic T lymphocyte antigen 4 at the maternal-fetal interface in women with unexplained pregnancy loss","volume":"93","author":"Lin","year":"2006","journal-title":"Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet"},{"issue":"5","key":"13","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1095\/biolreprod.102.010058","article-title":"B7 family molecules are favorably positioned at the human maternal-fetal interface","volume":"68","author":"Hunt","year":"2003","journal-title":"Biol Reprod"},{"issue":"9","key":"14","first-page":"4122","article-title":"Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus","volume":"158","author":"Miller","year":"1997","journal-title":"J Immunol Baltim Md 1950"},{"issue":"2","key":"15","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1084\/jem.20050019","article-title":"A critical role for the programmed death ligand 1 in fetomaternal tolerance","volume":"202","author":"Sayegh","year":"2005","journal-title":"J Exp Med"},{"issue":"11","key":"16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Schreiber","year":"2002","journal-title":"Nat Immunol"},{"issue":"1","key":"17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1600-065X.2011.01002.x","article-title":"Gimme shelter: the immune system during pregnancy","volume":"241","author":"Betz","year":"2011","journal-title":"Immunol Rev"},{"issue":"1","key":"18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jri.2010.01.005","article-title":"Major histocompatibility complex (MHC)-mediated immune regulation of decidual leukocytes at the fetal-maternal interface","volume":"85","author":"Claas","year":"2010","journal-title":"J Reprod Immunol"},{"issue":"1","key":"19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cell.2012.06.020","article-title":"Maternal-fetal immune tolerance, block by block","volume":"150","author":"Lafaille","year":"2012","journal-title":"Cell"},{"issue":"6","key":"20","first-page":"445","article-title":"Regulatory T cells and their role in pregnancy","volume":"63","author":"Zenclussen","year":"2010","journal-title":"Am J Reprod Immunol N Y N 1989"},{"issue":"12","key":"21","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2009-11-252940","article-title":"Thymic stromal lymphopoietin from trophoblasts induces dendritic cell-mediated regulatory TH2 bias in the decidua during early gestation in humans","volume":"116","author":"Li","year":"2010","journal-title":"Blood"},{"issue":"3","key":"22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct multiplexed measurement of gene expression with color-coded probe pairs","volume":"26","author":"Mitton","year":"2008","journal-title":"Nat Biotechnol"},{"key":"23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40425-015-0088-7","article-title":"nCounter() PanCancer Immune Profiling Panel (NanoString Technologies, Inc., Seattle, WA)","volume":"3","author":"Cesano","year":"2015","journal-title":"J Immunother Cancer"},{"key":"24","unstructured":"nSolver with Nanostring PanCancer Immune Kit. Available at: http:\/\/wwwnanostringcom\/applications\/technology."},{"issue":"9","key":"25","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/2326-6066.CIR-15-0095","article-title":"Tumoral Immune Resistance Mediated by Enzymes That Degrade Tryptophan","volume":"3","author":"Van den Eynde","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"26","unstructured":"Epacadostat Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Full Text View - ClinicalTrials.gov [Internet]. Available from: https:\/\/clinicaltrialsgov\/ct2\/show\/NCT02042430?term=ido1&rank=3."},{"key":"27","unstructured":"DEC-205\/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission - Full Text View - ClinicalTrials.gov [Internet]. Available from: https:\/\/clinicaltrialsgov\/ct2\/show\/NCT02166905?term=ido1&rank=2."},{"key":"28","unstructured":"IDO Inhibitor in Advanced Solid Tumors - Full Text View - ClinicalTrials.gov [Internet]. Available from: https:\/\/clinicaltrialsgov\/ct2\/show\/NCT02048709?term=ido1&rank=10."},{"key":"29","unstructured":"A Phase 1\/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With INCB024360 or Placebo in Subjects With Unresectable or Metastatic Melanoma - Full Text View - ClinicalTrials.gov [Internet]. Available from: https:\/\/clinicaltrialsgov\/ct2\/show\/NCT01604889?term=ido1&rank=9."},{"key":"30","first-page":"230","article-title":"The role of placental tryptophan catabolism","volume":"5","author":"Stocker","year":"2014","journal-title":"Front Immunol"},{"issue":"5380","key":"31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1126\/science.281.5380.1191","article-title":"Prevention of allogeneic fetal rejection by tryptophan catabolism","volume":"281","author":"Mellor","year":"1998","journal-title":"Science"},{"issue":"2","key":"32","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.coi.2006.01.002","article-title":"Indoleamine 2,3-dioxygenase, tumor-induced tolerance and counter-regulation","volume":"18","author":"Munn","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"33","doi-asserted-by":"publisher","first-page":"13506","DOI":"10.18632\/oncotarget.3642","article-title":"PDL1 expression in inflammatory breast cancer is frequent and predicts for the pathological response to chemotherapy","volume":"6","author":"van Laere","year":"2015","journal-title":"Oncotarget"},{"issue":"12","key":"34","first-page":"6822","article-title":"Tumor cell programmed death ligand 1-mediated T cell suppression is overcome by coexpression of CD80","volume":"186","author":"Ostrand-Rosenberg","year":"2011","journal-title":"J Immunol Baltim Md 1950"},{"issue":"5","key":"35","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s12015-013-9455-2","article-title":"Human placental mesenchymal stem cells (pMSCs) play a role as immune suppressive cells by shifting macrophage differentiation from inflammatory M1 to anti-inflammatory M2 macrophages","volume":"9","author":"Knawy","year":"2013","journal-title":"Stem Cell Rev"},{"issue":"6","key":"36","first-page":"2650","article-title":"Human chorionic gonadotropin as a central regulator of pregnancy immune tolerance","volume":"190","author":"Zenclussen","year":"2013","journal-title":"J Immunol Baltim Md 1950"},{"issue":"3","key":"37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Nagaraj","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.celrep.2015.06.024","article-title":"CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function","volume":"12","author":"Garrett","year":"2015","journal-title":"Cell Rep"},{"issue":"9","key":"39","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Gabrilovich","year":"2015","journal-title":"J Clin Invest"},{"key":"40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jri.2015.11.001","article-title":"New insights into myeloid-derived suppressor cells and their roles in feto-maternal immune cross-talk","volume":"113","author":"Lu","year":"2016","journal-title":"J Reprod Immunol"},{"key":"41","article-title":"Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-\u03b2\/\u03b2-catenin pathway","author":"Zhao","year":"2016","journal-title":"Mol Hum Reprod"},{"issue":"3","key":"42","first-page":"201","article-title":"Recent Insight into the Role of the PD-1\/PD-L1 Pathway in Feto-Maternal Tolerance and Pregnancy","volume":"74","author":"Liao","year":"2015","journal-title":"Am J Reprod Immunol N Y N 1989"},{"key":"43","first-page":"497","article-title":"Regulatory B cells and tolerance in transplantation: from animal models to human","volume":"4","author":"Brouard","year":"2013","journal-title":"Alloimmunity Transplant"},{"issue":"6","key":"44","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/aji.12157","article-title":"Cutting Edge: IL-10-Producing Regulatory B Cells in Early Human Pregnancy","volume":"70","author":"Zenclussen","year":"2013","journal-title":"Am J Reprod Immunol"},{"issue":"4","key":"45","first-page":"90","article-title":"Regulatory B10 Cells Restore Pregnancy Tolerance in a Mouse Model","volume":"89","author":"Zenclussen","year":"2013","journal-title":"Biol Reprod"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T14:26:46Z","timestamp":1596724006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,11]]},"references-count":45,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12,13]]}},"alternative-id":["13306","27852037"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13306","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,11]]}}}